蔡磊：对一些患者来说，渐冻症这个恶魔已被“秒杀”

Core Insights - The article highlights the determination of Cai Lei, who has been diagnosed with ALS (Amyotrophic Lateral Sclerosis) for six years, to combat the disease despite its historical challenges and lack of significant breakthroughs over the past 200 years [2][33]. Research and Collaboration - In 2025, Cai Lei's team collaborated with over 60 top research teams globally and partnered with more than 50 biotech companies and numerous hospitals, leading to nearly 100 research projects focused on ALS [2]. - The collaboration resulted in 15 drug pipelines and therapeutic technologies achieving clinical transformation breakthroughs [2]. Technological Innovation - Cai Lei has transitioned from being a patient to a core initiator and promoter of a research collaboration system, leveraging AI to enhance research efficiency [33][40]. - The "ALS AI Research Brain" platform, developed in 2024, has evolved into a super-intelligent entity that surpasses the capabilities of hundreds of human researchers, significantly improving the efficiency of research and discovery [41]. Clinical Developments - The AI platform has enabled the discovery of potential pathways for curing ALS in preclinical animal models, including methods like complete immune reconstruction through bone marrow transplantation [42]. Community Impact - The New Year's open letter included testimonials from eight patients with SOD1 gene mutation who reported improvements after using drugs developed in collaboration with Chinese scientists [29][30]. - Cai Lei's message emphasizes hope and resilience, stating that every seemingly insurmountable challenge can be overcome, including ALS [44].